Range Low Price High Price Comment
30 days $133.39 $156.84 Monday, 29th Apr 2024 ASND stock ended at $140.15. This is 3.13% more than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 4.36% from a day low at $136.48 to a day high of $142.43.
90 days $128.67 $161.00
52 weeks $76.02 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Jan 29, 2016 $19.04 $19.04 $19.04 $19.04 64 100
Jan 28, 2016 $18.18 $18.18 $18.18 $18.18 46 300
Jan 27, 2016 $18.08 $18.08 $18.08 $18.08 30 100
Jan 26, 2016 $18.61 $18.61 $18.61 $18.61 34 100
Jan 25, 2016 $18.26 $18.26 $18.26 $18.26 42 900
Jan 22, 2016 $18.25 $18.25 $18.25 $18.25 45 900
Jan 21, 2016 $16.46 $16.46 $16.46 $16.46 25 500
Jan 20, 2016 $16.15 $16.15 $16.15 $16.15 80 600
Jan 19, 2016 $16.52 $16.52 $16.52 $16.52 51 800
Jan 15, 2016 $16.84 $16.84 $16.84 $16.84 42 800
Jan 14, 2016 $16.15 $16.15 $16.15 $16.15 36 000
Jan 13, 2016 $14.90 $14.90 $14.90 $14.90 40 800
Jan 12, 2016 $14.70 $14.70 $14.70 $14.70 36 100
Jan 11, 2016 $14.10 $14.10 $14.10 $14.10 82 100
Jan 08, 2016 $14.49 $14.49 $14.49 $14.49 53 100
Jan 07, 2016 $16.65 $16.65 $16.65 $16.65 72 300
Jan 06, 2016 $17.87 $17.87 $17.87 $17.87 18 800
Jan 05, 2016 $18.02 $18.02 $18.02 $18.02 31 700
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT